Skip to content
Dx

ICD-10-CM 2027 diagnosis code

B38.3Cutaneous coccidioidomycosis

✓ Billable / specificCC — complication/comorbidity

B38.3 is a valid, billable ICD-10-CM code for cutaneous coccidioidomycosis. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.

Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data

About B38.3

B38.3 is the ICD-10-CM diagnosis code for cutaneous coccidioidomycosis. It belongs to category B38 (coccidioidomycosis), block B35-B49 (mycoses) and chapter 1 (certain infectious and parasitic diseases). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

Within B38 (coccidioidomycosis), B38.3 is specifically for cutaneous coccidioidomycosis. Related codes cover acute pulmonary coccidioidomycosis (B38.0), chronic pulmonary coccidioidomycosis (B38.1), pulmonary coccidioidomycosis, unspecified (B38.2), meningitis (B38.4), disseminated coccidioidomycosis (B38.7), other forms of coccidioidomycosis (B38.8) and unspecified (B38.9).

As a secondary diagnosis it is a CC (complication or comorbidity), which can move an inpatient stay into the "with CC" MS-DRG of its family, unless the principal diagnosis excludes it.

In MS-DRG v44.0, it is part of the grouping logic for DRG 606 (Minor Skin Disorders with MCC, relative weight 1.5728), DRG 607 (Minor Skin Disorders without MCC, relative weight 0.8772), DRG 974 (HIV with Major Related Condition with MCC, relative weight 3.0506), DRG 975 (HIV with Major Related Condition with CC, relative weight 1.3252) and DRG 976 (HIV with Major Related Condition without CC/MCC, relative weight 0.8124), in MDC 09 (Diseases and Disorders of the Skin, Subcutaneous Tissue and Breast) and MDC 25 (Human Immunodeficiency Virus Infections), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.

Before ICD-10, this condition was coded in ICD-9-CM as 114.1 (primary extrapulmonary coccidioidomycosis).

Notes that apply from higher levels

Instructions written at a parent level also apply to B38.3.

Alphabetic index entries

2 entries

Terms in the official ICD-10-CM index that lead to B38.3.

MS-DRG v44.0 grouping

All DRGs →

Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.

ICD-9-CM equivalent

Converter →
  • 114.1Primary extrapulmonary coccidioidomycosisapproximate

From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
  • No changes since FY2016.

Common questions about B38.3

Is B38.3 billable?

Yes. B38.3 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).

Can B38.3 be used as a principal diagnosis?

Yes. The Medicare Code Editor doesn't restrict B38.3 as a principal diagnosis.

Is B38.3 a CC or MCC?

B38.3 is a CC (complication or comorbidity) under MS-DRG v44.0, unless excluded by the principal diagnosis.

What DRG does B38.3 group to?

B38.3 is used in the MS-DRG v44.0 logic for MS-DRG 606 (Minor Skin Disorders with MCC), MS-DRG 607 (Minor Skin Disorders without MCC), MS-DRG 974 (HIV with Major Related Condition with MCC), MS-DRG 975 (HIV with Major Related Condition with CC) and MS-DRG 976 (HIV with Major Related Condition without CC/MCC). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.

What is the ICD-9 code for B38.3?

The CMS General Equivalence Mappings map B38.3 to ICD-9-CM 114.1.